Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bendamustine Combined With Bortezomib for Relapsed/Refractory Multiple Myeloma
NCT00920855Phase 2Completed
- Sponsor
- Cephalon, Inc.
- Start
- Jun 2009
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bendamustine in multiple myeloma (MM), sponsored by Cephalon, Inc.. Started Jun 2009; status: completed.
02
Drugs
bendamustine
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00920855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00920855.